Table 1.
Target gene | Primers | Sequence (5′-3′) | Amplicon length (bp) |
---|---|---|---|
GAPDH | Forward Reverse |
CATGGCCTTCCGTGTTCCTA TACTTGGCAGGTTTCTCCAGG |
75 |
IL-1α | Forward Reverse |
CCCATGATCTGGAAGAGACCA CAAACTTCTGCCTGACGAGC |
99 |
IL-1β | Forward Reverse |
TGCCACCTTTTGACAGTGATG AAGGTCCACGGGAAAGACAC |
254 |
TNF-α | Forward Reverse |
CCACCACGCTCTTCTGTCTA GAGGCCATTTGGGAACTTCTCATC |
74 |
C1q | Forward Reverse |
AGGACTGAAGGGCGTGAAAG TGGACTCTCCTGGTTGGTGA |
139 |
NR1 | Forward Reverse |
CAGGTGGAGTTGAGCACCAT ATGGGACTTGAGTATGGACAGG |
255 |
NR2A | Forward Reverse |
GCGTTCAGAAGTGGTGGACT GAGGCGCTGAAGGGTTCAAG |
117 |
NR2B | Forward Reverse |
GATTCTGCATTGTGAGCCGC AGCTCGTCGACTCTCTTGGT |
267 |
GluA1 | Forward Reverse |
GGACAACTCAAGCGTCCAGA CGCCACATCTGCTCTTCCATA |
271 |
GluA2 | Forward Reverse |
CCCGGAAGATTGGGTACTGG ACGCTCATTCCCTTCAAGCA |
176 |
GR | Forward Reverse |
GGCAAAGGCGATACCAGGATT AGGAGCAAAGCATAGCAGGT |
145 |
MR | Forward Reverse |
GGCCAAGGTACTTCCAGGATT CCCTGGCACAGCTCATACAT |
204 |